Endotoxin testing ensures pharmaceutical and medical device safety by detecting toxic substances from bacteria such as Gram-negative bacteria. In this context, variational inference (V) finds application by efficiently estimating complex probabilistic distributions, crucial in assessing endotoxin presence. For instance, in probabilistic graphical models applied to healthcare, V enables scalable analysis of large datasets, such as inferring underlying topics from medical documents. This combined approach enhances safety standards in the medical field by both detecting harmful substances and providing efficient probabilistic inference for decision-making.
Global Endotoxin and Pyrogen Testing Market valued at USD 1.14 billion in 2023 is projected to reach USD 2.67 billion by 2031 and will grow at a CAGR of 11.30% during the forecast period of 2024-2031.
To know more, visit https://www.databridgemarketresearch.com/reports/global-endotoxin-and-pyrogen-testing-market
Below are the Top Endotoxin and Pyrogen Testing companies with a Significant Market Share:
Rank
|
Company
|
Overview
|
Product Portfolio
|
Sales Geographical Coverage
|
Developments
|
1.
|
PALL CORPORATION
|
Pall Corporation is a global leader in filtration, separation, and purification solutions, including endotoxin and pyrogen testing. They offer a range of products such as filters and testing equipment for pharmaceutical and biotechnology industries to ensure product safety and compliance with regulatory standards.
|
|
Europe, Middle East and Africa, Americas, and Asia-Pacific
|
In December 2018, Pall Corporation (A Subsidiary of Danaher) established the Center of Excellence (CoE) for biotech-integrated solutions in Shanghai, China. This new excellence center opened by the company, equipped with advanced equipment and platforms has increased the production capacity of the products leading to balance in meeting the demand of the people in the region.
|
2.
|
EUROFINS SCIENTIFIC
|
Eurofins Scientific is a leading international group of laboratories providing a comprehensive range of analytical testing services, including endotoxin and pyrogen testing. Their expertise in microbiological testing enables accurate detection and quantification of harmful substances, crucial for ensuring the safety of pharmaceutical and medical device products.
|
|
Europe, Middle East and Africa, South America, North America, and Asia-Pacific
|
In March 2016, Eurofins Scientific acquired AMS Laboratories Pty Ltd., an Australia-based independent supplier of analytical and cGMP Quality Control services for medical devices and biopharmaceutical products. This acquisition done by the company has strengthened the foothills of the company in biopharmaceutical products testing in Australia region.
|
3.
|
Lonza
|
Lonza is a Swiss multinational company specializing in life sciences and biotechnology, offering endotoxin and pyrogen testing services and products. With a focus on quality control and regulatory compliance, Lonza provides solutions for the pharmaceutical and healthcare industries to detect and mitigate risks associated with endotoxins and pyrogens.
|
|
Europe, Middle East and Africa, Americas, and Asia-Pacific
|
In October 2020, Lonza unveiled its latest PyroCell MAT System to detect various pyrogens sensitively and sustainably without the need for laboratory animals. The product was launched with a full solution with optimized MAT reagents from Sanquin and media and accessories from Lonza. The company's introduction of this new product has boosted its credibility and market demand.
|
4.
|
SGS Société Générale de Surveillance SA
|
SGS is a global leader in inspection, verification, testing, and certification services, including endotoxin and pyrogen testing. Their extensive network of laboratories and expertise in regulatory compliance ensures reliable and accurate testing for pharmaceutical and medical device manufacturers worldwide.
|
|
Europe, Middle East and Africa, South America, North America, and Asia-Pacific
|
In March 2006, SGS SA opened a new laboratory specialized in Quality Control testing of pharmaceuticals, biopharmaceuticals, and medical devices in Singapore. This new laboratory opening has increased the company's international network in QC operations, thereby increasing its demand in the market.
|
5.
|
THERMO FISHER SCIENTIFIC INC.
|
Thermo Fisher Scientific is a leading provider of analytical instruments, equipment, reagents, and services for various industries, including endotoxin and pyrogen testing in pharmaceutical and biotechnology sectors. Their portfolio includes a range of testing kits, instruments, and software solutions designed to meet the stringent requirements of regulatory agencies and ensure product safety and quality.
|
|
Europe, Middle East and Africa, South America, North America, and Asia-Pacific
|
In February 2012, Thermo Fisher Scientific Inc. announced the launch of its new product named Pierce LAL Chromogenic Endotoxin Quantitation Kit, which is useful for the sensitive detection and measurement of endotoxins in protein, peptide or antibody samples. This new product launched by the company has increased its protein estimation portfolio in the market.
|
Conclusion
In the endotoxin and pyrogen testing market, key players such as Pall Corporation, Eurofins Scientific, Lonza, SGS Société Générale de Surveillance SA, and Thermo Fisher Scientific play pivotal roles. These companies offer comprehensive solutions, from testing services to cutting-edge equipment and regulatory expertise, ensuring the safety and compliance of pharmaceutical and medical device products. With a focus on innovation, quality assurance, and global reach, they collectively contribute to advancing standards in product safety and regulatory compliance, thus safeguarding public health and fostering trust within the industry.